25 apr: Europa/luk: Regnskaber gav nye stigninger
26 apr: Selskabernes forventninger - torsdag den 26 april
25-04-2012 18:13:00

2ndUPDATE: Apple Surges Back Above $600, Erasing Most Of Recent Loss

Relateret indhold
Relateret debat
10 maj - 
Apple er hastigt på vej ind i Augmented Reality (AR) og..
13 apr - 
Nå, det var faktisk det der stod ordret :P Jeg gætter p..
13 apr - 
Teknologien har eksisteret eksperimentelt længe, men er..

--Apple surges back above $600 following blowout quarterly results

--Apple retraces 76% of what it lost in previous 11 sessions

--Wall Street analysts help fuel gains by lifting price targets

(Updates with prices, added analyst comments)

By Tomi Kilgore and Matt Jarzemsky

Of DOW JONES NEWSWIRES

NEW YORK -(Dow Jones)- Shares of Apple Inc. (AAPL) surged back above $600 Wednesday as Wall Street applauded the technology bellwether's strong quarterly results.

The stock recently traded up 9.1% to $611.29, erasing in one fell swoop much of what it lost over the previous 11 sessions. The stock had been up as much as 10.3% at an intraday high of $618, the highest price seen since April 18.

At current prices, the stock has retraced 67% of the decline from its April 9 all-time closing high of $636.23. Ahead of the earnings report, Tuesday's close of $560.28 was a six-week low.

A host of Wall Street analysts have helped fuel the gains by suggesting the shares still have a lot further to rally.

Goldman Sachs bumped up Apple's price target to $850 from $750, Wedbush Morgan lifted its target to $800 from $570, and Canaccord Genuity raised its target to $775 from $740.

J.P. Morgan said "Apple remains in a league of its own," while Gabelli & Co. said Apple's valuation "remains very compelling."

Apple's rise far outpaced its peers', and the rally was having a historic impact on the broader market. At one point Wednesday, the stock's heavy weighting contributed about 6 points to the S&P 500-stock index's overall gain, or about one-third of its climb, according to S&P Indices senior index analyst Howard Silverblatt. An influence of that degree would be the biggest daily impact Apple has ever had on the index.

The S&P 500 was recently up 14 points, or 1%, at 1386. Meanwhile, the Dow Jones Industrial Average, which doesn't include Apple as a component, was up 76 points, or 0.6%, at 13077.

In addition, shares of Apple suppliers also rose Wednesday. Chip maker OmniVision Technologies Inc. (OVTI) gained 6.7% in late-morning trade, on pace for its biggest increase since March 6. Cirrus Logic (CRUS) climbed 8.7% and Broadcom Corp. (BRCM) added 5.1%.

Ahead of Apple's results, investors had grown increasingly worried that iPhone sales might disappoint, as carriers Verizon Communications Inc. (VZ) and AT&T Inc. (T) reported year-over-year iPhone sales declines.

But Apple said after Tuesday's close that it sold 35.1 million iPhone units last quarter, well above expectations of about 30 million. And earnings rose 94% from year-ago levels to $11.62 billion, or $12.30 a share, on revenue growth of 59%, to $39.19 billion.

Analysts surveyed by FactSet Research had been expecting, on average, earnings of $10.16 a share on revenue of $36.96 billion.

Dave Rolfe, chief investment officer at Wedgewood Partners, said it was a "classic dominant Apple quarter."

"The only chink in the armor, which is really not a chink at all, iPad numbers came in in-line," Rolfe said.

-By Tomi Kilgore, Dow Jones Newswires; 212-416-2470; tomi.kilgore@dowjones.com

(END) Dow Jones Newswires

April 25, 2012 12:13 ET (16:13 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Novo hvirvles ind i ny retssag i USA - citat

29-05-2017 10:51:00
Novo Nordisk er igen blevet sagsøgt i USA - denne gang som konsekvens af markante prisstigninger på selskabets diabetesmedicin Victoza.Det skriver flere medier, heriblandt branchemediet Medwatch, der citerer Fierce Pharma.Ifølge det amerikanske medie er sagen anlagt af diabetespatienten Ruth Johnson ved en føderal domstol i Californien som en såkaldt "class action"-sag, der kan få direkte effekt f..

Novo søger om at få fordele på Tresibas indlægsseddel i USA

29-05-2017 06:34:18
Novo Nordisk har ansøgt de amerikanske lægemiddelmyndigheder, FDA, om lov til at supplere indlægssedlen for sit langtidsvirkende insulin Tresiba med data fra et stort hjerte-kar-studie med insulinet.Det fremgår af en meddelelse lørdag.Hjerte-kar-studiet ved navn Devote opfyldte sit primære mål, idet det viste "ikke-inferiøritet" med hensyn til alvorlige kardiovaskulære hændelser med Tresiba sammen..

Dong-topchef om salg af oliedivision: Den samlede pris er rigtig fin

24-05-2017 16:33:25
Flere iagttagere har kaldt salgsprisen for Dongs olie- og gasforretning lav, men hos energiselskabet selv mener man, at prisen er rigtig god, når man ser på det samlede regnestykke.Sådan lyder det fra Dongs administrerende direktør, Henrik Poulsen, efter at selskabet onsdag har gjort klar til et salg til den britiske kemikoncern Ineos.- Vi har fået en rigtig fin pris for forretningen. Vi har fået ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas' USA-chef: De næste fem år bliver de bedste nogensinde
2
Pandora: Amerikansk forhandler sendes til tælling efter regnskab
3
Pandora/Sydbank: Signet-regnskab kan give spekulanter mod på fald - NY
4
Aktier/tendens: Pandora kan få flere stryg i grønt marked
5
Novo hvirvles ind i ny retssag i USA - citat

Relaterede aktiekurser

Apple Inc 153,61 -0,2% Fald i aktiekurs
AT&T Inc 38,12 -0,3% Fald i aktiekurs
Verizon Communications I.. 45,32 0,0% Stigning i aktiekurs
Cirrus Logic Inc 66,43 0,9% Stigning i aktiekurs
Verizon Comm 34,91 1,7% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
29. maj 2017 15:15:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20170517.1 - EUROWEB4 - 2017-05-29 15:15:57 - 2017-05-29 15:15:57 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x